Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry

Xiaoxia Liu; Guoze Feng; Sabrina Marler; Menno V. Huisman; Professor Gregory Lip; Changsheng Ma

doi:10.1186/s12959-023-00527-x

Related publications

Article2019

Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme

Michał Mazurek, Jonathan L. Halperin, Menno V. Huisman, Hans‐Christoph Diener, Sérgio Dubner, Chang Sheng, Kenneth J. Rothman, Jeff S. Healey, Christine Teutsch, Miney Paquette, Lionel Riou França, Shihai Lu, Dorothee B. Bartels, Professor Gregory Lip

Article2018

Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program

Michał Mazurek, Menno V. Huisman, Kenneth J. Rothman, Miney Paquette, Christine Teutsch, Hans‐Christoph Diener, Sérgio Dubner, Jonathan L. Halperin, Kristina Zint, Lionel Riou França, Shihai Lu, Professor Gregory Lip

Article2022

Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry

Menno V. Huisman, Christine Teutsch, Shihai Lu, Hans‐Christoph Diener, Sérgio Dubner, Jonathan L. Halperin, Changsheng Ma, Kenneth J. Rothman, Ragna Lohmann, Venkatesh Kumar Gurusamy, Dorothee B. Bartels, Professor Gregory Lip

Article2022

Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry

Wern Yew Ding, Peter Calvert, Dhiraj Gupta, Menno V. Huisman, Professor Gregory Lip

Article2021

Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program

José López‐Sendón, David Alonso‐Rodríguez, Gonzalo Barón‐Esquivias, Juan Cosı́n-Sales, Francisco Marı́n, Jordi Galera-Llorca, Natalia de las Heras, Sabrina Marler, Menno V. Huisman, Professor Gregory Lip